S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall episode artwork

EPISODE · Mar 13, 2025 · 14 MIN

S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall

from Treating Together · host Targeted Oncology

In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.

Episode metadata supplied by the publisher feed · Published Mar 13, 2025

Embed this episode

Ready to play

S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall

0:00 14:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 14 minutes long.

When was this Treating Together episode published?

This episode was published on March 13, 2025.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!